I agree but they didnt even have that in the Chairmans address or the CEO presentation.
Pretty strange IMO. If they're waiting for minutes, why not say that?
As well, there is clear precedence in giving guidance on a meeting without the notes and this was done last year with GVHD via something along the lines of 'It seems the FDA are unlikely to approve our application at this time' and that was before the notes were provided.
They have done this numerous times and also in the Chairman address, there was a rather glowing paragraph on CHF - yet no reference to CLBP at all.
again, IMO, this is clearly deliberate and there has to be a reason.
I agree but they didnt even have that in the Chairmans address...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
0.065(5.99%) |
Mkt cap ! $1.324B | |||
| Open | High | Low | Value | Volume |
| $1.12 | $1.20 | $1.11 | $20.08M | 17.25M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 30925 | $1.22 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.10 | 100000 | 1 |
View Market Depth
| Last trade - 15.59pm 06/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.15 |
Change
0.065 ( 5.63 %) |
||||
| Open | High | Low | Volume | ||
| $1.12 | $1.20 | $1.12 | 3730649 | ||
| Last updated 15.59pm 06/05/2024 ? | |||||
| MSB (ASX) Chart |